CALL DATE: Oct. 31, 2007 TIME: 8:30 a.m. Eastern Time HOST: Dr. Candace
Kendle, Chairman and CEO
CINCINNATI, Oct. 10 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL) will conduct a telephone conference call and simultaneous webcast Oct. 31 at 8:30 a.m. Eastern Time to discuss its financial results for the Third Quarter 2007. A question and answer session will follow.
To access the live webcast, go to http://www.kendle.com or http://www.videonewswire.com/event.asp?id=43011. Instructions for accessing the webcast are provided at both sites. The webcast will be archived at http://www.kendle.com (click on "Investors") shortly after the call for on-demand replay through 5 p.m. Eastern Time on Nov. 30, 2007. Please note that webcast participants will not be able to ask questions.
System requirements for the webcast include Windows Media Player software and at least a 28.8 Kbps connection to the Internet. Media Player is downloadable at no charge from http://www.microsoft.com/windows/windowsmedia/default.aspx.
Conference Call Instructions
To register (RSVP) for the telephone conference call, U.S. and Canadian participants should dial (800) 223-7104. Participants outside North America should dial (706) 645-6519.
To participate in the telephone conference call, interested parties in the United States and Canada should dial (800) 399-0069. Participants outside North America should dial (706) 643-3694. A replay will be available through 5 p.m. Eastern Time on Nov. 30 by dialing (706) 645-9291 and entering conference ID number 5447273.
Kendle International Inc. (Nasdaq: KNDL) is among the world's leading global clinical research organizations and is the fourth-largest provider of Phase II-IV clinical development services worldwide. We deliver innovative and robust clinical development solutions -- from first-in-human studies through market launch and surveillance -- to help the world's biopharmaceutical companies maximize product life cycles and grow market share.
Our global clinical development business is focused on five regions -- North America, Europe, Asia/Pacific, Latin America and Africa -- to meet customer needs. With the expertise of our more than 3,000 associates worldwide, Kendle has conducted clinical trials and provided regulatory and pharmacovigilance services in more than 80 countries. The company was named the "Top CRO to Work With" in the Thomson CenterWatch 2007 Survey of U.S. Investigative Sites.
Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 1200, Cincinnati, OH 45202 or from the Company's Web site at http://www.kendle.com.
Copyright©2007 PR Newswire.
All rights reserved